Exudative AMD Refractory To Anti-VEGF Therapy in Patients with Malignancy

26.01.2018

Canberra Retina Clinic Administrator

Download as PDF

Recent Posts

Comparative evaluation of Aflibercept and Ranibizumab on central choroidal subfield thickness (CCST) in patients treated for wet AMD
Topographic Correlation of Retinal Pigment Epithelial Detachment to Choroidal Filling Defects in Central Serous Chorioretinopathy
The Effect of the Reflux Bleb of Anti-VEGF Injections on Central Macular Thickness
Rebound Tonometry Intra Ocular Pressure Screening of Patients Treated with Anti Vascular Endothelial Growth Factor Inhibitors
Exudative AMD Refractory To Anti-VEGF Therapy in Patients with Malignancy

CANBERRA RETINA CLINIC

CONTACT US

Phone: 02 6282 1783

Fax: 02 6285 1556

Comparative evaluation of Aflibercept and Ranibizumab on central choroidal subfield thickness (CCST) in patients treated for wet AMD